ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease

Diabetes Care

Volumn 24, Issue 12, 2001, Pages 2115-2120

  Fava, Stephen ^a,b   Azzopardi, Joseph ^a   Ellard, Sian ^b   Hattersley, Andrew T ^b  

^a ST LUKE S HOSPITAL   (Malta)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; DIABETIC NEPHROPATHY; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROGNOSIS; SURVIVAL RATE;

AGED; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC NEPHROPATHIES; FEMALE; GENOTYPE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; MALE; MIDDLE AGE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM (GENETICS); PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0035654003     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.12.2115     Document Type: Article

References (14)

1. Seaquist ER, Goetz F, Rich SR, Barbosa J: Familial clustering of diabetic kidney disease. N Engl J Med 320:1161-1165, 1989
2. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jansen JS, Deckert T, Parving H: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
3. Quinn M, Angelico MC, Warram JH, Krolewski: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945, 1996
4. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 33: 438-443, 1990
5. Fava S, Azzopardi J, Hattersley A, Watkins P: Increased prevalence of protein-uria in diabetic sibs of proteinuric type 2 diabetic subjects. Am J Kidney Dis 35: 708-712, 2000
6. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nuleic Acids Res 20:1433, 1992
7. Schmidt S, Ritz E: Genetic determinants of diabetic renal disease and their impact on therapeutic intervention. Kid Int Suppl 63:527-531, 1997
8. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular renal risk. J Hypertens 15:1579-1592, 1997
9. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T: Meta-analysis of association of insertion/deletion polymorphism of angiotensin 1-convening enzyme gene with diabetic nephropathy. Diabetologia 41:47-53, 1998
10. Parving HH: Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Dtabetologia 41:745-759, 1998
11. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O: Angiotensin 1 converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kid Int 50:657-664, 1996
12. Huang XH, Ratalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimaki T: Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed up for 9 years. Nephron 80:17-24, 1998
13. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC: Effect of proteinuria on mortality in NIDDM. Diabetes 37:1499-1504, 1988
14. Stiegler H, Standyl, Schulz K, Roth R, Lehmacher W: Morbidity, mortality and albuminuria in type 2 diabetic patients: a three year prospective study of a random cohort in general practice. Diabet Med 9:646-653, 1992